SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
SANUWAVE Health, Inc.NASDAQ: SNWV
EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026
EPS (Basic) remains negative
Q1 FY2026 EPS (Basic) was -$0.17, compared with -$0.66 a year earlier. Trailing-twelve-month EPS (Basic) was $1.76.
Context
- EPS (Basic) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 1 analysts of -$0.08 (-105.8%) for the fiscal year ending Dec 2026, a slowdown from the +119.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$0.17-123.9% QoQ
- Last fiscal yearDec 2025
- $1.38+119.6% YoY
- LTMMar 2026
- $1.76+120.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +74.2% | -494.7% | -569.0 pp |
| 1 year | +119.6% | -105.8% | -225.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 1.38 USD
- Year-over-year change
- +119.6%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.38 | +119.6% |
| FY2024 | 2024-12-31 | (7.03) | +42.3% |
| FY2023 | 2023-12-31 | (12.19) | -73.6% |
| FY2022 | 2022-12-31 | (7.02) | +64.4% |
| FY2021 | 2021-12-31 | (19.72) | — |
EPS (Basic) vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 EPS (Basic) of $1.76 is the highest of the 11 companies compared; the peer median is -$1.17.
- Its year-over-year change of +120.9% is the highest of 11, against a peer median of +10.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1.76 | +120.9% | — | |
| LTM Mar 2026 | -$0.71 | +27.7% | — | |
| LTM Mar 2026 | -$0.91 | +20.9% | — | |
| LTM Mar 2026 | -$0.98 | -78.2% | — | |
| LTM Dec 2025 | -$1.15 | -27.8% | — | |
| LTM Mar 2026 | -$1.17 | +14.6% | — | |
| LTM Mar 2026 | -$1.17 | +40.3% | — | |
| LTM Mar 2026 | -$2.16 | +5.7% | — | |
| LTM Mar 2026 | -$2.36 | -90.3% | — | |
| LTM Mar 2026 | -$4.16 | +87.4% | — | |
| LTM Mar 2026 | -$33.93 | -654.0% | — | |
| Peer median (excluding SNWV) | -$1.17 | +10.1% | — | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| Weighted Avg Shares | 1.38M | 1.47M | 2.12M | 4.46M | 8.56M |
| Weighted Avg Shares (Diluted) | 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.